Suchergebnisse - "Thuluvath, Paul J"

PubPharm (12)

1

Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Reddy, K. | Pol, S. | Thuluvath, P. | +18

2

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection

enthalten in: Annals of hepatology | 2016

von Rodriguez-Torres, M. | Lawitz, E. | Yangco, B. | +20

3

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Everson, G. | Sims, K. | Thuluvath, P. | +17

CommentIn: Liver Int. 2016 Feb;36(2):181-4. - PMID 26781595

4

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

enthalten in: The New England journal of medicine | 2015

von Feld, J. | Jacobson, I. | Hézode, C. | +103

CommentIn: N Engl J Med. 2016 Apr 28;374(17):1688-9

5

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection : A Randomized Trial

enthalten in: Annals of internal medicine | 2015

von Everson, G. | Towner, W. | Davis, M. | +15

6

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

enthalten in: Gastroenterology | 2015

von Lawitz, E. | Makara, M. | Akarca, U. | +10

7

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

8

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

enthalten in: Journal of hepatology | 2015

von Hassanein, T. | Sims, K. | Bennett, M. | +16

CommentIn: J Hepatol. 2015 May;62(5):996-9. - PMID 25747660

9

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection : ALLY-3 phase III study

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Nelson, D. | Cooper, J. | Lalezari, J. | +23

CommentIn: Turk J Gastroenterol. 2016 Jan;27(1):89-90. - PMID 26728866

10

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

enthalten in: Gastroenterology | 2014

von Everson, G. | Sims, K. | Rodriguez-Torres, M. | +19